Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MicroMed Technology was a medical device company that pioneered the development of miniaturized ventricular assist devices (VADs) for patients suffering from end-stage heart failure. The company's primary product, the DeBakey VAD, was an axial-flow pump based on technology co-developed by NASA and the legendary heart surgeon Dr. Michael DeBakey. This device was significantly smaller than first-generation VADs, allowing for easier implantation and reduced patient discomfort. MicroMed successfully obtained CE Mark approval in Europe and conducted extensive clinical trials in the United States. In 2013, the company was acquired by ReliantHeart, which integrated the technology into its HeartAssist5 product line.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MicroMed Technology.